As mentioned,
a number of studies are planned based on this cohort.
The key outcome variables will be diagnosis of GDM, various adverse pregnancy outcomes such as macrosomia, stillbirth, congenital abnormality, pre – eclampsia and postpartum metabolic abnormalities such as hyperglycaemia, hyperlipidaemia and anthropometric details of both the mother and child.
The exposure variables will be various demographic and socioeconomic details, obstetric history including previous pregnancy complications, anthropometric measurements and clinical parameters e.g. plasma glucose and lipid profiles in the various trimesters, treatment plan and postpartum breastfeeding.